Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomization	STARTED	Arm I: Placebo	518
Randomization	STARTED	Arm II: Atrasentan	520
Randomization	COMPLETED	Arm I: Placebo	496
Randomization	COMPLETED	Arm II: Atrasentan	500
Randomization	NOT COMPLETED	Arm I: Placebo	22
Randomization	NOT COMPLETED	Arm II: Atrasentan	20
Eligible for Protocol Assigned Treatment	STARTED	Arm I: Placebo	496
Eligible for Protocol Assigned Treatment	STARTED	Arm II: Atrasentan	500
Eligible for Protocol Assigned Treatment	COMPLETED	Arm I: Placebo	169
Eligible for Protocol Assigned Treatment	COMPLETED	Arm II: Atrasentan	185
Eligible for Protocol Assigned Treatment	NOT COMPLETED	Arm I: Placebo	327
Eligible for Protocol Assigned Treatment	NOT COMPLETED	Arm II: Atrasentan	315

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00134056/flow